http://www.nasdaq.com/article/gilead-sciences-inc-gild-president-and-ceo-john-f-milligan-sold-16-million-of-shares-cm878680

President and CEO of Gilead Sciences Inc ( GILD ) John F Milligan sold 220,000 shares of GILD on 11/13/2017 at an average price of $72.88 a share. The total sale was $16 million. Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases. Gilead Sciences Inc has a market cap of $93.8 billion; its shares were traded at around $71.81 with a P/E ratio of 8.15 and P/S ratio of 3.43. The dividend yield of Gilead Sciences Inc stocks is 2.84%. Gilead Sciences Inc had annual average EBITDA growth of 53.00% over the past five years.  CEO Recent Trades:  Directors and Officers Recent Trades:    This article first appeared on GuruFocus . 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
 

 

https://oracleexaminer.com/2017/11/17/is-gilead-sciences-inc-nasdaqgild-a-good-investment/

Technical Indicators and Signals The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Gilead Sciences Inc. (NASDAQ:GILD) for the period of 9-Day stands at 41.75% while the stochastic %D for the same period stands at 32.62%. The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Gilead Sciences Inc. (NASDAQ:GILD) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”. Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Gilead Sciences Inc. (NASDAQ:GILD) while 20-100 Day MACD Oscillator indicates “Sell”. Bollinger band is a volatility indicator of a certain security, currently Gilead Sciences Inc. (NASDAQ:GILD)’s 20-Day Bollinger Band indicates “Hold”. About Company Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugs that are safer, easier for patients to tolerate and more effective. Previous Day Activity Analysis On the last trading day, Gilead Sciences Inc. (NASDAQ:GILD) opened the session at $71.75 and after going up 0.84% closed at $72.41. The stock gained 0.66 points in the last trade. Gilead Sciences Inc. (NASDAQ:GILD)’s stock fluctuated in the range of $71.25 and $72.60 during the previous active session. Gilead Sciences Inc. (NASDAQ:GILD) traded with the volume of 7.41 Million with average volume of 9.55 Million. The stock has MEDIUM volatility on the last trading session. Currently the Beta for the company remains at 1.17 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.58 and 32.66 respectively. Currently the Insider Ownership of the shares of Gilead Sciences Inc. (NASDAQ:GILD) is at 0.2% and the shares outstanding are 1.31 Billion. Important Ratio Analysis Some important ratios to consider here for Gilead Sciences Inc. (NASDAQ:GILD) are discussed below: Dividend yield of Gilead Sciences Inc. (NASDAQ:GILD) stands at 2.87% whereas Price to Earnings P/E ratio stands at 8.24 while Forward P/E shows the value of 10.51. The Price to Sale P/S and Price to Book P/B shows the value of 3.44 and 3.81 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.33 and 10.39 correspondingly. The Quick Ratio of Gilead Sciences Inc. (NASDAQ:GILD) stands at 3.6 while the Current Ratio depicts the value of 3.7. Return on Assets ROA of Gilead Sciences Inc. (NASDAQ:GILD) is at 19.4% whereas, Return on Equity ROE and Return of Investment ROI of Gilead Sciences Inc. (NASDAQ:GILD) stand at 53.4% and 31% respectively. The payout ratio of Gilead Sciences Inc. (NASDAQ:GILD) stands at 22.9%. Stock Performance Analysis The stock performance of Gilead Sciences Inc. (NASDAQ:GILD) on the basis of 5 day trade show the dip of -0.84% whereas, the monthly performance of the stock shows decrease of -9.5%. The quarterly performance of the stock remained in green zone with the value of 0.42% while six month performance of the shares of Gilead Sciences Inc. (NASDAQ:GILD) remained bullish with the count of 12.74%. The yearly and YTD performance of Gilead Sciences Inc. (NASDAQ:GILD) remained mix at -4.72% and 1.12% respectively. 

https://www.economicsandmoney.com/2017/11/16/reading-the-tea-leaves-for-gilead-sciences-inc-gild-4/

The recent progress in the stock of Gilead Sciences, Inc. (NASDAQ:GILD) has alerted everyone to look out for right opportunity to invest. Many experts agree that the truth about a stock is best reflected in the way it moves on the chart. For this stock, the chart has a lot to say about future performance. How has the stock performed recently? Gilead Sciences, Inc. (NASDAQ:GILD) in the last month has decreased -10.25%. Shares are now up over the past year, outperforming the broad market by -100% and outperformed a peer group of similar companies by 52%. After the latest session, which saw the stock close at a price of $71.81, GILD sits below its 52-week high. Gilead Sciences, Inc. (NASDAQ:GILD) has been trading in a bullish manner, based on the relative positions of the stock’s 20 and 200 day moving averages. Momentum indicators 
     (adsbygoogle = window.adsbygoogle || []).push({});
 Of course, these surface-level price movements don’t tell us much about the direction that GILD may be headed in the future. Fortunately, there is way to use the speed and magnitude of these price changes to predict future performance, thanks to what are known as momentum indicators. As momentum slows, it might be a sign that a support or resistance level has been reached, and that a trend is about to reverse. Two such indicators are the RSI (Relative Strength Index) and the Stochastic %k Oscillator, which fluctuate on a scale of 0 to 100. A reading above 70 indicates that a stock is overvalued, and a reading below 30 implies that it is undervalued. The 20-day RSI for GILD is 32.93%, which suggests that the stock is not particularly expensive or cheap, and not predisposed to a reactive price movement based on this measure. The 20-day Stochastic %k measure, which sits at 10.06%, tells a different story, and suggests that GILD currently trades in oversold territory. What do the trading volumes reveal? Volume patterns can also be useful for predicting future performance. When trading activity is abnormally high, it’s often a sign that the market feels particularly strong in one way or another about the future direction of a stock. Gilead Sciences, Inc. (GILD) average trading volume of 9,675,345 during the past month is 4.09% above its average volume over the past year, indicating that investors have been more active than usual in the stock in recent times. What do the analysts think? GILD is currently undervalued by -15.42% relative to the average 1-year price target of $84.90 taken from a group of Wall Street Analysts. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.40, which implies that analysts are generally neutral in their outlook for GILD over the next year. How risky is the stock?  No study on the valuation of a stock is complete without taking into account risk. When analyzing the systematic risk associated with a stock, analysts look at beta, which measures the stock’s volatility relative to the overall market. Gilead Sciences, Inc. (NASDAQ:GILD) has a beta of 1.17, compared to a beta of 1 for the market, which implies that the stock’s price movements are more extreme than the market as a whole. GILD therefore has a above average level of market risk. During the past couple of weeks, GILD average daily volatility was 16.00%, which is 5.92 percentage points lower than the average volatility over the past 100 days. 



(adsbygoogle = window.adsbygoogle || []).push({});
 

https://investorplace.com/2017/11/trade-day-gilead-sciences-inc-gild-2/

To receive further updates on this Gilead Sciences, Inc. (NASDAQ:GILD) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of SlingShot Trader today.  Gilead Sciences, Inc. (NASDAQ:GILD) has been struggling since its earnings announcement in late October, even though the company beat revenue estimates by $110 million, beat earnings estimates by $0.14 per share and upgraded its EPS guidance from $0.86-$0.93 to $1.02-$1.77. To add insult to injury, the stock just got hit with another downgrade from Argus — who dropped the stock from Buy to Hold — citing concerns the company is increasing R&D spending on the new CART-T therapies the company acquired when it bought Kite Pharma at the same time its blockbuster hepatitis C and HIV products are seeing declining sales. These concerns, coupled with the general pricing pressure the market is applying to biotechnology stocks, are likely to push GILD lower. The stock is currently sitting around support at $72 (which was support in mid-August and resistance in late June), but we expect it to move down to its next support level at $69 (which was support in early July and resistance in early May). ‘Buy to open’ the GILD December 70 Put (GILD171215P00070000) for a maximum price of $1.50. Follow our Facebook page to receive each Trade of the Day direct to your News Feed — and join the conversation. You can learn more about identifying price patterns and using them to project how far you think a stock is going to move in our Advanced Technical Analysis Program. InvestorPlace advisers John Jagerson and S. Wade Hansen, both Chartered Market Technician (CMT) designees, are co-founders of LearningMarkets.com, as well as the co-editors of SlingShot Trader, a trading service designed to help you make options profits by trading the news. Get in on the next SlingShot Trader trade and get 1 free month today by clicking here. Article printed from InvestorPlace Media, https://investorplace.com/2017/11/trade-day-gilead-sciences-inc-gild-2/. ©2017 InvestorPlace Media, LLC 

https://www.stocknewsjournal.com/2017/11/14/the-case-for-and-against-gilead-sciences-inc-gild-7/

Gilead Sciences, Inc. (GILD) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $72.85, down from yesterday’s close by -1.25%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data. Fundamental Analysis Money managers are always interested in a company that can find the right recipe of fundamental data because it reflects something important going on underneath the surface. Gilead Sciences, Inc. (GILD) currently trades with a market capitalization of $95.14 Billion. That value represents a market adjusting for revenues that have been falling by -13.17 % on a quarterly year/year basis as of the company’s last quarterly report. 
     (adsbygoogle = window.adsbygoogle || []).push({});
 The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For GILD, the company currently has $11.51 Billion of cash on the books, which is offset by $1.75 Billion current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $12.1 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.69 on a per share basis this quarter. Perhaps, that suggests something about why 76.60% of the outstanding share supply is held by institutional investors. Technical Analysis Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Gilead Sciences, Inc. recorded a 52-week high of $86.27. It is now trading 13.42% off that level. The stock is trading $80.29 its 50-day moving average by 7.44%. The stock carved out a 52-week low down at $63.76. In recent action, Gilead Sciences, Inc. (GILD) has made a move of -8.88% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.32, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.51% with $1.30 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of GILD. 

http://www.nasdaq.com/article/gild-makes-notable-cross-below-critical-moving-average-cm877182

In trading on Tuesday, shares of Gilead Sciences Inc (Symbol: GILD) crossed below their 200 day moving average of $72.09, changing hands as low as $71.15 per share. Gilead Sciences Inc shares are currently trading down about 2% on the day. The chart below shows the one year performance of GILD shares, versus its 200 day moving average:     Looking at the chart above, GILD's low point in its 52 week range is $63.76 per share, with $86.27 as the 52 week high point - that compares with a last trade of $71.35.    According to the ETF Finder at ETF Channel, GILD makes up 8.88% of the Biotech ETF (Symbol: BBH) which is trading lower by about 0.7% on the day Tuesday.   Click here to find out which 9 other dividend   stocks recently crossed below their 200 day moving average » makeArticleAd();        Click here to find out which 9 other dividend   stocks recently crossed below their 200 day moving average »  
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
 

 

https://stocknewsgazette.com/2017/11/14/what-do-insider-trends-have-to-say-about-gilead-sciences-inc-gild/

Recent insider trends for Gilead Sciences, Inc. (NASDAQ:GILD) have caught the attention of investors. Patters in insider activity can help analysts formulate an outlook for a stock. In the case of GILD, the data has a lot to say about how the stock might perform going forward. Institutions own 75.10% of Gilead Sciences, Inc. (GILD)’s shares. The total value of these holdings, in millions, is $72,368. Among active positions in the latest quarter, 707 holders increased their positions by a total of 72.51 million shares, 755 holders decreased the positions by a total of 68.29 million shares, and 164 holders held their positions. This works out to a net increase in ownership of 4.22 million shares, and suggests that institutions are feeling bullish about the stock. Among new and sold out positions, 117 holders initiated new positions by a total of 11.76 million shares and 98 holders exited their positions by a total of 15.75 million shares. This nets out to a decrease of 4 million shares and is another bearish sign for GILD. In the last three months, insiders executed a total of 13 trades. 1 of these were buys and 12 were sells. Insider ownership decreased by a total of 578901 shares, which suggests that GILD’s key executives are feeling less optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: insiders executed 21 buys and 46 sells, and ownership decreased by a net of 1.48 million shares. 
     (adsbygoogle = window.adsbygoogle || []).push({});
 Short interest is another tool that analysts use to gauge investor sentiment. It represents the number of a stock’s shares that are being shorted by investors. Gilead Sciences, Inc. (NASDAQ:GILD)’s short interest is 19.6 million shares, or 1.51% of the float. This represents a decrease of -19% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks. Given what the insider ownership patterns are saying, it makes sense to consider the technicals to see if these pieces of information reach the same conclusion about the outlook for GILD. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that GILD is a Strong sell, which implies that GILD is expected to underperform the market based on prior trading patterns. Conclusion 
(adsbygoogle = window.adsbygoogle || []).push({});
 Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bearish. Technical indicators (also) suggest that Gilead Sciences, Inc. (NASDAQ:GILD) is overvalued. 

https://www.economicsandmoney.com/2017/11/13/should-investors-take-a-bite-out-of-gilead-sciences-inc-gild-2/

Recent price movements in the stock of Gilead Sciences, Inc. (NASDAQ:GILD) have caught the attention of the investment community. Many analysts use price trends and patterns to predict future performance, and we can glean some important insights about GILD by examining the chart. How has the stock performed recently? Gilead Sciences, Inc. (NASDAQ:GILD) in the last month has decreased -9.12%. Shares are now up over the past year, outperforming the broad market by -100% and underperformed a peer group of similar companies by -35%. After the latest session, which saw the stock close at a price of $73.77, GILD sits below its 52-week high. Gilead Sciences, Inc. (NASDAQ:GILD) has been trading in a bullish manner, based on the relative positions of the stock’s 20 and 200 day moving averages. Momentum indicators 
     (adsbygoogle = window.adsbygoogle || []).push({});
 Of course, these surface-level price movements don’t tell us much about the direction that GILD may be headed in the future. To do this, analysts often study the speed and magnitude of a stock’s price movements with what are known as momentum indicators. The logic is that as a stock’s momentum slows, it may be nearing key support or resistance levels and possibly the end of a current trend. Two such indicators are the RSI (Relative Strength Index) and the Stochastic %k Oscillator, which fluctuate on a scale of 0 to 100. A reading above 70 indicates that a stock is overvalued, and a reading below 30 implies that it is undervalued. The 20-day RSI for GILD is 35.83%, which suggests that the stock is not particularly expensive or cheap, and not predisposed to a reactive price movement based on this measure. The 20-day Stochastic %k measure, which sits at 11.35%, tells a different story, and suggests that GILD currently trades in oversold territory. What do the trading volumes reveal? In addition to price, analysts use volume trends to predict future performance. The level of trading activity in a stock is often a good proxy for the level of interest and enthusiasm for the name within the investment community. A sudden increase in activity can be a sign that investors are trading in anticipation of a catalyst. Gilead Sciences, Inc. (GILD) average trading volume of 9,345,395 during the past month is 0.71% above its average volume over the past year, indicating that investors have been more active than usual in the stock in recent times. What do the analysts think? GILD is currently undervalued by -13.11% relative to the average 1-year price target of $84.90 taken from a group of Wall Street Analysts. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.40, which implies that analysts are generally neutral in their outlook for GILD over the next year. How risky is the stock?  Absolute price performance isn’t the only thing analysts consider when predicting future performance: volatility matters as well. Beta, which measures the stock’s volatility relative to the overall market, is a simple but effective metric for assessing risk. Gilead Sciences, Inc. (NASDAQ:GILD) has a beta of 1.17, compared to a beta of 1 for the market, which implies that the stock’s price movements are more extreme than the market as a whole. GILD therefore has a above average level of market risk. During the past couple of weeks, GILD average daily volatility was 15.01%, which is 6.38 percentage points lower than the average volatility over the past 100 days. 



(adsbygoogle = window.adsbygoogle || []).push({});
 

http://www.usacommercedaily.com/2017/11/15/inspecting-more-closely-technicals-of-gilead-sciences-inc-gild-2/

With all other things going on, Gilead Sciences, Inc. (NASDAQ:GILD) has been on a free fall — declining -3 percent in just three months. It looks like traders are not happy with the stock. On the other side, analysts now consider Gilead Sciences, Inc. a neutral, and a technical analysis of the stock is setting somewhat neutral outlook for now.  Let’s talk about the gap between analyst price targets for the next 12 months and Gilead Sciences, Inc. (GILD)‘s current share price. Normally this spread should be in positive territory, indicating that analysts expect an investment’s value to increase over time. So is with Gilead Sciences, Inc.. The median target of analyst views collected by Yahoo Finance was as much as $13.85 below GILD’s recent stock price. That’s the optimistic view from Wall Street.  The stock has actually made sharp losses in the past year, as the company has gathered a -7.3% return in the past twelve months. But even with this move, there is still plenty of room for the company to come back from a longer term perspective, and especially if we look to recent lows for the company as well.  The company’s share price is down -21.25% from previous highs of around $86.27 per share on September 08, 2017. On the bright side, the company’s share price has been on the rebound, up more than 33.31% since hitting lows of $63.76 on June 16, 2017.  Finally, from a technical perspective, there’s a strong possibility that the stock could enter into a new bull market after finding strong support between $68.64 and $69.89. In terms of pullbacks, $72.56 level is the first resistance point. Technical analysis can help recognize key technical price levels in the stock. Investors can use these support and resistance levels to refine their entries and exits from stocks.  Gilead Sciences, Inc. (NASDAQ:GILD) price is pointing towards neither exit nor entry barriers, according to a technical analysis tool called the Relative Strength Index (RSI). Last session Gilead Sciences, Inc. RSI was seen at 23.69. RSI measures the speed and change of a stock price to warn investors when a stock’s momentum has carried it too far. An RSI reading above 80 indicates that a stock is overbought while anything below 20 is oversold.  With these kinds of figures it is worthy to note that Gilead Sciences, Inc. (GILD) has been put into a neutral territory, but there are few other spots to consider. The Stochastic %K for GILD is 13.67. Stochastics is a momentum indicator that uses basic support and resistance levels and integrates with the trend to give accurate buy or sell signals to traders. For stochastics, readings below 20 are considered oversold and you would only take buy signals if the indicator is below that level. A value of 80 is considered overbought and sell signals occurring below that level would be ignored. This leads to longer trades and should result in fewer losses.  14-day Williams %R for Gilead Sciences, Inc. (NASDAQ:GILD) moved to around 88.36. The interpretation of Williams %R is very similar to that of the stochastic oscillator, except that the stochastic oscillator has internal smoothing. The oscillator ranges from 0 to -100. No matter how fast a security advances or declines, Williams %R will always fluctuate within this range. Overbought and oversold levels can be used to identify unsustainable price extremes. Simply put, readings in the range of 80% to 100% indicate that the security is oversold while readings in the 0% to 20% range suggest it is overbought. 
 

http://www.nasdaq.com/article/gild-makes-notable-cross-below-critical-moving-average-cm877182

In trading on Tuesday, shares of Gilead Sciences Inc (Symbol: GILD) crossed below their 200 day moving average of $72.09, changing hands as low as $71.15 per share. Gilead Sciences Inc shares are currently trading down about 2% on the day. The chart below shows the one year performance of GILD shares, versus its 200 day moving average:     Looking at the chart above, GILD's low point in its 52 week range is $63.76 per share, with $86.27 as the 52 week high point - that compares with a last trade of $71.35.    According to the ETF Finder at ETF Channel, GILD makes up 8.88% of the Biotech ETF (Symbol: BBH) which is trading lower by about 0.7% on the day Tuesday.   Click here to find out which 9 other dividend   stocks recently crossed below their 200 day moving average » makeArticleAd();        Click here to find out which 9 other dividend   stocks recently crossed below their 200 day moving average »  
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
 

 

